Plasma heart-type fatty acid binding protein level in acute ischemic stroke: Comparative analysis with plasma S100B level for diagnosis of stroke and prediction of long-term clinical outcome

Clinical Neurology and Neurosurgery

Volumn 115, Issue 4, 2013, Pages 405-410

  Park, So Young ^a   Kim, Mi Hwa ^a   Kim, Ok Joon ^a   Ahn, Hee Jung ^a   Song, Ji Ye ^a   Jeong, Ju Yeon ^a   Oh, Seung Hun ^a  

^a CHA University   (South Korea)

Author keywords

Biomarker; Diagnosis; Heart type fatty acid binding protein; S100B; Stroke

Indexed keywords

FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; PROTEIN S100B; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; S100 PROTEINS; SPECTROPHOTOMETRY, ULTRAVIOLET; STROKE; TREATMENT OUTCOME;

EID: 84875211703     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2012.06.004     Document Type: Article

References (29)

1. B.C. Lee, and J.K. Roh Korean Stroke Registry International experience in stroke registries: Korean Stroke Registry American Journal of Preventive Medicine 31 Suppl. 2 2006 S243 S245
2. K.W. Jung, Y.J. Won, S. Park, H.J. Kong, J. Sung, and H.R. Shin Cancer statistics in Korea: incidence, mortality and survival in 2005 Journal of Korean Medical Science 24 2009 995 1003
3. J.D. van Wijngaarden, M. Dirks, R. Huijsman, L.W. Niessen, I.N. Fabbricotti, and D.W. Dippel Hospital rates of thrombolysis for acute ischemic stroke: the influence of organizational culture Stroke 40 2009 3390 3392
4. I.L. Katzan, M.D. Hammer, E.D. Hixson, A.J. Furlan, A. Abou-Chebl, and D.M. Nadzam Utilization of intravenous tissue plasminogen activator for acute ischemic stroke Archives of Neurology 61 2004 346 350
5. M. Rothermundt, M. Peters, J.H.M. Prehn, and V. Arolt S100B in brain damage and neurodegeneration Microscopy Research and Technique 60 2003 614 632
6. C. Foerch, O.C. Singer, T. Neumann-Haefelin, R. du Mesnil de Rochemont, H. Steinmetz, and M. Sitzer Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction Archives of Neurology 62 2005 1130 1134
7. S. Korfias, G. Stranjalis, A. Papadimitriou, C. Psachoulia, G. Daskalakis, and A. Antsaklis Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts Current Medicinal Chemistry 13 2006 3719 3731
8. M.T. Wunderlich, A.D. Ebert, T. Kratz, M. Goertler, S. Jost, and M. Herrmann Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage Stroke 30 1999 1190 1195
9. M. Stroick, M. Fatar, A. Ragoschke-Schumm, K. Fassbender, T. Bertsch, and M.G. Hennerici Protein S-100B - a prognostic marker for cerebral damage Current Medicinal Chemistry 13 2006 3053 3060
10. D.T. Laskowitz, S.E. Kasner, J. Saver, K.S. Remmel, E.C. Jauch, and BRAIN Study Group Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study Stroke 40 2009 77 85
11. J.R. Lynch, R. Blessing, W.D. White, H.P. Grocott, M.F. Newman, and D.T. Laskowitz Novel diagnostic test for acute stroke Stroke 35 2004 57 63
12. M.A. Reynolds, H.J. Kirchick, J.R. Dahlen, J.M. Anderberg, P.H. McPherson, and K.K. Nakamura Early biomarkers of stroke Clinical Chemistry 49 2003 1733 1739
13. M. Furuhashi, and G.S. Hotamisligil Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets Nature Reviews Drug Discovery 7 2008 489 503
14. M. Ishino, Y. Takeishi, T. Niizeki, T. Watanabe, J. Nitobe, and T. Miyamoto Risk stratification of chronic heart failure patients by multiple biomarkers: implications of BNP, H-FABP, and PTX3 Circulation Journal 72 2008 1800 1805
15. J. Liao, C.P. Chan, Y. Cheung, J. Lu, Y. Luo, and G.W.H. Cautherley Human heart-type fatty acid-binding protein for on-site diagnosis of early acute myocardial infarction International Journal of Cardiology 133 2009 420 423
16. J.A. Alhashemi Diagnostic accuracy of a bedside qualitative immunochromatographic test for acute myocardial infarction American Journal of Emergency Medicine 24 2006 149 155
17. C.P. Cannon, C.M. Gibson, C.T. Lambrew, D.A. Shoultz, D. Levy, and W.J. French Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction The Journal of the American Medical Association 283 2000 2941 2947
18. G. Haltern, S. Peiniger, A. Bufe, G. Reiss, H. Gülker, and T. Scheffold Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction American Journal of Cardiology 105 2010 1 9
19. M.T. Wunderlich, T. Hanhoff, M. Goertler, F. Spener, J.F.C. Glatz, and C.W. Wallesch Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke Journal of Neurology 252 2005 718 724
20. F. Herisson, O. Delaroche, E. Auffray-Calvier, B. Duport, and B. Guillon Ischemia-modified albumin and heart fatty acid-binding protein: could early ischemic cardiac biomarkers be used in acute stroke management? Journal of Stroke & Cerebrovascular Diseases 19 2010 279 282
21. O. Akpinar, S. Geyik, A. Acikalin, Y. Karakan, and O. Tiryaki H-FABP in the early diagnosis of stroke Journal of Neurology 256 2009 1922 1923
22. C.G. Zimmermann-Ivol, P.R. Burkhard, J. Le Floch-Rohr, L. Allard, D.F. Hochstrasser, and J.C. Sanchez Fatty acid binding protein as a serum marker for the early diagnosis of stroke: a pilot study Molecular and Cellular Proteomics 3 2004 66 72
23. S.E. Kasner, J.A. Chalela, J.M. Luciano, B.L. Cucchiara, E.C. Raps, and M.L. McGarvey Reliability and validity of estimating the NIH stroke scale score from medical records Stroke 30 1999 1534 1537
24. L.B. Goldstein, M.R. Jones, D.B. Matchar, L.J. Edwards, J. Hoff, and V. Chilukuri Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria Stroke 32 2001 1091 1098
25. M.M. Pelsers, T. Hanhoff, D. Van der Voort, B. Arts, M. Peters, and R. Ponds Brain-and heart-type fatty acid-binding proteins in the brain: tissue distribution and clinical utility Clinical Chemistry 50 2004 1568 1575
26. W. Whiteley, M.C. Tseng, and P. Sandercock Blood biomarkers in the diagnosis of ischemic stroke: a systematic review Stroke 39 2008 2902 2909
27. R.A. Bakay, and A.A. Ward Jr. Enzymatic changes in serum and cerebrospinal fluid in neurological injury Journal of Neurosurgery 58 1983 27 37
28. E. Akbal, M. Özbek, F. Günes, Ö. Akyürek, K. Üreten, and T. Delibasi Serum heart type fatty acid binding protein levels in metabolic syndrome Endocrine 36 2009 433 437
29. A. Boscheri, C. Wunderlich, M. Langer, S. Schoen, B. Wiedemann, and D. Stolte Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk American Heart Journal 160 2010 294 300